Metraipolis › archive › dc_cdab1e775002
Network Pharmacology and Experimental Validation of the Anti-Inflammatory Effect of Modified Qianzheng Powder in Atherosclerosis — Europe PMC PMID:40619667
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40619667
- DOI
- 10.2174/0113862073376112250602092950
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:52:00.406Z
- SHA-256 of the archived text
5caaa1c4bc4c97af6b60bf6e2dceb7872535fb209fdae55a95079b3ec3bb7159- Stable URL of this page
https://metraipolis.com/documento/dc_cdab1e775002
How to cite
Network Pharmacology and Experimental Validation of the Anti-Inflammatory Effect of Modified Qianzheng Powder in Atherosclerosis — Europe PMC PMID:40619667 — Europe PMC (en), https://europepmc.org/article/MED/40619667 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cdab1e775002 (Metraipolis archive dc_cdab1e775002, sha256 5caaa1c4bc4c97af6b60bf6e2dceb7872535fb209fdae55a95079b3ec3bb7159)
BibTeX
@misc{dccdab1e775002,
title = {Network Pharmacology and Experimental Validation of the Anti-Inflammatory Effect of Modified Qianzheng Powder in Atherosclerosis — Europe PMC PMID:40619667},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40619667},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cdab1e775002; sha256 5caaa1c4bc4c97af6b60bf6e2dceb7872535fb209fdae55a95079b3ec3bb7159},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40619667. Agents can read the archived copy with the MCP tool read_document.